Weight-adjusted dosing of tinzaparin in pregnancy

Thrombosis Research

Volumn 131, Issue 2, 2013, Pages

  Gibson, P S ^a,b   Newell, K ^b   Sam, D X ^a,b   Mansoor, A ^b   Jiang, X ^b   Tang, S ^b   Ross, S ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Pregnancy; Tinzaparin; Venous thromboembolism; Weight adjusted dosing

Indexed keywords

BLOOD CLOTTING FACTOR 10A; TINZAPARIN;

ADVERSE OUTCOME; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FETUS MALFORMATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PRURITUS; SKIN BRUISING; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM; WEIGHT GAIN;

ADULT; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84872294995     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.11.018     Document Type: Article

References (23)

1. Centre for Maternal, Child Enquiries (CMACE) Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom BJOG 118 Suppl. 1 2011 1 203
2. J. Chang, L.D. Elam-Evans, C.J. Berg, J. Herndon, L. Flowers, and K.A. Seed Pregnancy-related mortality surveillance -United States, 1991-1999 Surveillance Summaries - February 21, 2003 MMWR 52(No. SS-2) 2003 1 8
3. Health Canada Special Report on Maternal Mortality and Severe Morbidity in Canada - Enhanced Surveillance: The Path to Prevention 2004 Minister of Public Works and Government Services Canada Ottawa
4. R.B. Gherman, T.M. Goodwin, B. Leung, J.D. Byrne, R. Hethumumi, and M. Montoro Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy Obstet Gynecol 94 5 Pt 1 1999 730 734
5. S.M. Bates, I.A. Greer, S. Middeldorp, D.L. Veenstra, A.M. Prabulos, and P.O. Vandvik VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl. Feb 2012 e691S e736S
6. E. Melissari, C.J. Parker, N.V. Wilson, G. Monte, C. Kanthou, and K.D. Pemberton Use of low molecular weight heparin in pregnancy Thromb Haemost 68 6 1992 652 656
7. F. Forestier, F. Daffos, and M. Capella-Pavlovsky Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound Thromb Res 34 6 1984 557 560
8. F. Forestier, F. Daffos, M. Rainaut, and F. Toulemonde Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy Thromb Haemost 57 2 1987 234
9. C. McLintock, T. Brighton, S. Chunilal, G. Dekker, N. McDonnell, and S. McRae Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period Aust N Z J Obstet Gynaecol 52 1 Feb 2012 14 22
10. A. James, and Committee on Practice Bulletins - Obstetrics Practice bulletin no. 123: thromboembolism in pregnancy Obstet Gynecol 118 3 Sep 2011 718 729
11. I.A. Greer, and A.J. Thomson The Acute Management of Thrombosis and Embolism During Pregnancy and the Puerperium Green-top Guideline No. 37b 2007 Royal College of Obstetricians and Gynaecologists
12. S. Middeldorp How I, treat pregnancy-related venous thromboembolism Blood 118 20 2011 5394 5400
13. D.A. Garcia, T.P. Baglin, J.I. Weitz, M.M. Samama, and American College of Chest Physicians Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl. Feb 2012 e24S e43S
14. L.A. Barbour, J.L. Oja, and L.K. Schultz A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation Am J Obstet Gynecol 191 3 2004 1024 1029
15. M.P. Smith, L.A. Norris, P.J. Steer, G.F. Savidge, and J. Bonnar Tinzaparin sodium for thrombosis treatment and prevention during pregnancy Am J Obstet Gynecol 190 2 2004 495 501
16. L.A. Norris, J. Bonnar, M.P. Smith, P.J. Steer, and G. Savidge Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy: A pharmacokinetic study Thromb Haemost 92 4 2004 791 796
17. F. Ní Ainle, A. Wong, N. Appleby, B. Byrne, C. Regan, and T. Hassan Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy Blood Coagul Fibrinolysis 19 7 Oct 2008 689 692
18. R.O. Powrie Principles for Drug Prescribing in Pregnancy K. Rosene-Montella, E.J. Keely, R.V. Lee, L.A. Barbour, Medical Care of the Pregnant Patient, 2e, American College of Physicians October 2007 ACP Press Philadelphia
19. J. Hirsh, K.A. Bauer, M.B. Donati, M. Gould, M.M. Samama, and J.I. Weitz Parenteral Anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 133 2008 141S 159S
20. J.A. Lykke, T. Grønlykke, and J. Langhoff-Roos Treatment of deep venous thrombosis in pregnant women Acta Obstet Gynecol Scand 87 11 2008 1248 1251
21. N.L. Shapiro, M.A. Kominiarek, E.A. Nutescu, A.B. Chevalier, and J.U. Hibbard Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience Pharmacotherapy 31 7 Jul 2011 678 685
22. A.F. Jacobsen, E. Qvigstad, and P.M. Sandset Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy BJOG 110 2 2003 139 144
23. E. Rey, and G.E. Rivard Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin Int J Gynaecol Obstet 71 1 Oct 2000 19 24